ArticlebioRxiv : the preprint server for biology2026
The Effects of Hypertension on Signaling Dynamics in Rare Renal Cell Types.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Hypertension (HTN) is the most prevalent risk factor for severe cardiovascular disease and can cause major renal damage, inflammation, and immune cell accumulation. Lymphatic endothelial cells (LECs) are involved in the removal of pro-inflammatory immune cells and cytokines and kidney-specific augmentation of lymphangiogenesis can prevent or reduce HTN. In our previous paper, we performed single-cell RNA sequencing (scRNAseq) on CD31+/podoplanin+ renal cells from mice that underwent angiotensin II-induced (A2HTN) or salt sensitive (SSHTN) models of HTN (and their respective controls) and identified populations of LECs, myeloid immune cells (MICs), and a novel multipotent population we dubbed support cells (SCs). Using NicheNet, we compared baseline signaling between these three cell types in control samples and differences in signaling between control and HTN samples in both LECs and SCs. Ligands with high regulatory potential were identified for all three cell types, with
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.